A systematic review and meta‐analysis of the relative benefit of dual versus single oral hypoglycaemic therapy following diagnosis with type 2 diabetes ( T2D )

Documenti analoghi

• Could continuous subcutaneous glucose sensors ( CGMS ) be repurposed to diagnose diabetes in equivocal or challenging cases?
  di: Martin B. Whyte, et al.
  Pubblicazione: (2025)
• Mortality in people with a diabetes foot ulcer: An update from the Salford podiatry clinic follow‐up study
  di: Adrian Heald, et al.
  Pubblicazione: (2024)
• Impact of level 2 hypoglycaemia on neuroaxonal damage biomarker in individuals with type 2 diabetes: A stepwise hypoglycaemic clamp study
  di: Harald Sourij, et al.
  Pubblicazione: (2025)
• The long‐term effect of bariatric/metabolic surgery versus pharmacologic therapy in type 2 diabetes mellitus patients: A systematic review and meta‐analysis
  di: Yumeng Yang, et al.
  Pubblicazione: (2024)
• The insulin‐like growth factor system and the progression of renal complications of type 2 diabetes
  di: Adrian Heald, et al.
  Pubblicazione: (2026)